Product NDC: | 66993-070 |
Proprietary Name: | Mefenamic Acid |
Non Proprietary Name: | mefenamic acid |
Active Ingredient(s): | 250 mg/1 & nbsp; mefenamic acid |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 66993-070 |
Labeler Name: | Prasco Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA015034 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20110711 |
Package NDC: | 66993-070-30 |
Package Description: | 30 CAPSULE in 1 BOTTLE (66993-070-30) |
NDC Code | 66993-070-30 |
Proprietary Name | Mefenamic Acid |
Package Description | 30 CAPSULE in 1 BOTTLE (66993-070-30) |
Product NDC | 66993-070 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | mefenamic acid |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20110711 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Prasco Laboratories |
Substance Name | MEFENAMIC ACID |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |